These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

553 related items for PubMed ID: 18495691

  • 1. IGF-II/mannose 6-phosphate receptor activation induces metalloproteinase-9 matrix activity and increases plasminogen activator expression in H9c2 cardiomyoblast cells.
    Chang MH, Kuo WW, Chen RJ, Lu MC, Tsai FJ, Kuo WH, Chen LY, Wu WJ, Huang CY, Chu CH.
    J Mol Endocrinol; 2008 Aug; 41(2):65-74. PubMed ID: 18495691
    [Abstract] [Full Text] [Related]

  • 2. IGF-II/mannose-6-phosphate receptor signaling induced cell hypertrophy and atrial natriuretic peptide/BNP expression via Galphaq interaction and protein kinase C-alpha/CaMKII activation in H9c2 cardiomyoblast cells.
    Chu CH, Tzang BS, Chen LM, Kuo CH, Cheng YC, Chen LY, Tsai FJ, Tsai CH, Kuo WW, Huang CY.
    J Endocrinol; 2008 May; 197(2):381-90. PubMed ID: 18434368
    [Abstract] [Full Text] [Related]

  • 3. Defective processing of the transforming growth factor-beta1 in azoxymethane-induced mouse colon tumors.
    Guda K, Claffey KP, Dong M, Nambiar PR, Rosenberg DW.
    Mol Carcinog; 2003 May; 37(1):51-9. PubMed ID: 12720300
    [Abstract] [Full Text] [Related]

  • 4. Insulin-like growth factor II receptor, transforming growth factor-beta, and Cdk4 expression and the developmental epigenetics of mouse palate morphogenesis and dysmorphogenesis.
    Melnick M, Chen H, Buckley S, Warburton D, Jaskoll T.
    Dev Dyn; 1998 Jan; 211(1):11-25. PubMed ID: 9438420
    [Abstract] [Full Text] [Related]

  • 5. Urokinase type plasminogen activator receptor is involved in insulin-like growth factor-induced migration of rhabdomyosarcoma cells in vitro.
    Gallicchio MA, Kaun C, Wojta J, Binder B, Bach LA.
    J Cell Physiol; 2003 Oct; 197(1):131-8. PubMed ID: 12942549
    [Abstract] [Full Text] [Related]

  • 6. Modulation of tissue plasminogen activator and plasminogen activator inhibitor-1 by transforming growth factor-beta in human retinal glial cells.
    Schacke W, Beck KF, Pfeilschifter J, Koch F, Hattenbach LO.
    Invest Ophthalmol Vis Sci; 2002 Aug; 43(8):2799-805. PubMed ID: 12147618
    [Abstract] [Full Text] [Related]

  • 7. Expression and localisation of extracellular matrix degrading proteases and their inhibitors during the oestrous cycle and after induced luteolysis in the bovine corpus luteum.
    Kliem H, Welter H, Kraetzl WD, Steffl M, Meyer HH, Schams D, Berisha B.
    Reproduction; 2007 Sep; 134(3):535-47. PubMed ID: 17709571
    [Abstract] [Full Text] [Related]

  • 8. Expression and localization of extracellular matrix-degrading proteinases and their inhibitors in the bovine mammary gland during development, function, and involution.
    Rabot A, Sinowatz F, Berisha B, Meyer HH, Schams D.
    J Dairy Sci; 2007 Feb; 90(2):740-8. PubMed ID: 17235151
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Brain-derived neurotrophic factor inducing angiogenesis through modulation of matrix-degrading proteases.
    Sun CY, Hu Y, Wang HF, He WJ, Wang YD, Wu T.
    Chin Med J (Engl); 2006 Apr 05; 119(7):589-95. PubMed ID: 16620701
    [Abstract] [Full Text] [Related]

  • 11. Leu27IGF2 plays an opposite role to IGF1 to induce H9c2 cardiomyoblast cell apoptosis via Galphaq signaling.
    Chen RJ, Wu HC, Chang MH, Lai CH, Tien YC, Hwang JM, Kuo WH, Tsai FJ, Tsai CH, Chen LM, Huang CY, Chu CH.
    J Mol Endocrinol; 2009 Dec 05; 43(6):221-30. PubMed ID: 19556392
    [Abstract] [Full Text] [Related]

  • 12. Roles of insulin-like growth factor II in cardiomyoblast apoptosis and in hypertensive rat heart with abdominal aorta ligation.
    Lee SD, Chu CH, Huang EJ, Lu MC, Liu JY, Liu CJ, Hsu HH, Lin JA, Kuo WW, Huang CY.
    Am J Physiol Endocrinol Metab; 2006 Aug 05; 291(2):E306-14. PubMed ID: 16825605
    [Abstract] [Full Text] [Related]

  • 13. Cellular response to latent TGF-beta1 is facilitated by insulin-like growth factor-II/mannose-6-phosphate receptors on MS-9 cells.
    Ghahary A, Tredget EE, Mi L, Yang L.
    Exp Cell Res; 1999 Aug 25; 251(1):111-20. PubMed ID: 10438576
    [Abstract] [Full Text] [Related]

  • 14. The effect of IL-1alpha on the expression of matrix metalloproteinases, plasminogen activators, and their inhibitors in osteoblastic ROS 17/2.8 cells.
    Fujisaki K, Tanabe N, Suzuki N, Mitsui N, Oka H, Ito K, Maeno M.
    Life Sci; 2006 Mar 20; 78(17):1975-82. PubMed ID: 16313928
    [Abstract] [Full Text] [Related]

  • 15. Type-2 IGF receptor: a multi-ligand binding protein.
    Braulke T.
    Horm Metab Res; 1999 Mar 20; 31(2-3):242-6. PubMed ID: 10226808
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Altered ligand binding by insulin-like growth factor II/mannose 6-phosphate receptors bearing missense mutations in human cancers.
    Devi GR, De Souza AT, Byrd JC, Jirtle RL, MacDonald RG.
    Cancer Res; 1999 Sep 01; 59(17):4314-9. PubMed ID: 10485478
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Urokinase plasminogen activator stimulates function of active forms of stromelysin and gelatinases (MMP-2 and MMP-9) in cirrhotic tissue.
    González-Cuevas J, Bueno-Topete M, Armendariz-Borunda J.
    J Gastroenterol Hepatol; 2006 Oct 01; 21(10):1544-54. PubMed ID: 16928215
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.